MsbA is an ATP-binding cassette (ABC) transporter responsible for flipping lipid A—a key component of lipopolysaccharide (LPS)—from the cytoplasmic to the periplasmic leaflet of the inner membrane in Gram-negative bacteria . In Burkholderia xenovorans, recombinant MsbA retains this function and is expressed with a His tag for purification . Its activity is vital for bacterial viability, as lipid A is a prerequisite for outer membrane assembly and pathogenicity .
MsbA binds lipid A with high affinity ( in µM range) and transports it via a "trap-and-flip" mechanism .
Conformational changes in MsbA widen the transmembrane portal to accommodate lipid A, as observed in X-ray structures (2.8 Å resolution) .
Simultaneous binding of lipid A and amphipathic drugs (e.g., daunorubicin) occurs at distinct sites, suggesting substrate promiscuity .
ATP hydrolysis drives the transition from inward- to outward-facing conformations .
Fluorescence quenching studies show nucleotide binding reduces lipid A affinity, indicating bidirectional communication between NBDs and TMDs .
MsbA is a validated drug target due to its essential role in LPS biogenesis. Key findings include:
Inhibitors targeting MsbA’s ATPase activity disrupt lipid A transport, compromising bacterial membrane integrity .
Structural studies reveal druggable pockets in the transmembrane cavity and periplasmic cleft .
The recombinant protein is expressed in E. coli and purified using affinity chromatography. Key steps involve:
Tagging: N-terminal His tag for Ni-NTA column purification .
Stability: Requires glycerol (5–50%) for long-term storage .
Activity: Retains ATPase function post-purification, confirming structural integrity .
This recombinant Burkholderia xenovorans Lipid A export ATP-binding/permease protein MsbA (msbA) is involved in lipopolysaccharide (LPS) biosynthesis. It facilitates the translocation of lipid A-core from the inner to the outer leaflet of the inner membrane. The protein's transmembrane domains (TMDs) form a pore in the inner membrane, while the ATP-binding domain (NBD) provides the necessary energy for this process.
KEGG: bxb:DR64_991
STRING: 266265.Bxe_A3290
The msbA gene in Burkholderia xenovorans LB400 is located on chromosome 1 of its multi-replicon genome. B. xenovorans LB400 possesses one of the largest known bacterial genomes at 9.73-Mbp, distributed across three replicons: chromosome 1 (4.9 Mbp), chromosome 2 (3.36 Mbp), and a megaplasmid (1.42 Mbp) . The msbA gene is specifically identified as Bxeno_A1155 or Bxe_A3290 in ordered locus names . The gene's placement on chromosome 1 rather than the smaller replicons is significant as this largest replicon typically experiences more stringent selective pressure and houses genes considered essential for core cellular functions .
The MsbA protein in B. xenovorans LB400 is a full-length protein of 597 amino acids characterized as a Lipid A export ATP-binding/permease protein with the Enzyme Commission number EC= 3.6.3.- . The protein functions as an ATP-dependent lipid A-core flippase that facilitates the transport of Lipid A across bacterial membranes. Its amino acid sequence reveals several critical domains:
Transmembrane domains that anchor the protein in the bacterial membrane
ATP-binding cassette (ABC) transporter signature motifs
A nucleotide-binding domain (NBD) characterized by Walker A and Walker B motifs
A substrate-binding domain
The protein belongs to the ABC transporter superfamily, which requires ATP hydrolysis to actively transport substrates across membranes .
For optimal preservation of recombinant B. xenovorans MsbA, researchers should:
Store the lyophilized protein at -20°C for short-term storage or -80°C for extended storage periods.
After reconstitution, prepare working aliquots to avoid repeated freeze-thaw cycles, which significantly degrade protein quality.
Maintain working aliquots at 4°C for no longer than one week.
Reconstitute in appropriate Tris-based buffer with 50% glycerol optimized for this specific protein.
For long-term storage of reconstituted protein, add glycerol to a final concentration of 5-50% and store in single-use aliquots at -20°C/-80°C .
The presence of glycerol in the storage buffer is particularly important for membrane proteins like MsbA as it helps maintain the native conformation by preventing denaturation during freeze-thaw cycles.
The expression and purification of functional recombinant B. xenovorans MsbA requires a methodical approach:
Expression System Selection:
E. coli is typically the preferred heterologous expression system for MsbA proteins, as demonstrated in similar studies with MsbA from other bacterial species .
Expression Protocol:
Clone the full-length msbA gene (1-597aa) from B. xenovorans LB400 into an expression vector with an N-terminal His-tag.
Transform into an E. coli expression strain optimized for membrane proteins (e.g., C41(DE3) or C43(DE3)).
Grow cultures at reduced temperatures (16-25°C) after induction to promote proper folding.
Include specific membrane protein-friendly detergents during cell lysis and purification steps.
Purification Strategy:
Solubilize membrane fraction using mild detergents (typically n-dodecyl-β-D-maltoside or LDAO).
Purify using nickel affinity chromatography targeting the His-tag.
Further purify using size exclusion chromatography to isolate properly folded protein.
Validate protein purity using SDS-PAGE (target >90% purity).
Verify protein functionality through ATPase activity assays .
The ABC transporter activity of B. xenovorans MsbA must be examined in context of the extensive genomic plasticity observed within the Burkholderia genus. Comparative analysis reveals:
Evolutionary Conservation:
Only approximately 44% of genes are conserved between B. xenovorans LB400 and Burkholderia cepacia complex strain 383, indicating significant divergence that may extend to MsbA functional properties .
Functional Adaptations:
The high genomic plasticity within Burkholderia (with B. xenovorans genome sizes varying from 7.4 to 9.73 Mbp among strains) suggests potential functional specialization of MsbA to accommodate different ecological niches .
Paralog Distribution:
Research indicates that 17.6% of B. xenovorans LB400 proteins have better paralogs within the same genome than orthologs in different genomes. This high rate of gene duplication and divergence potentially affects MsbA function through:
Substrate specificity alterations
Regulatory pathway differences
Differential expression patterns under varied environmental conditions
Researchers comparing MsbA activity across Burkholderia species should employ standardized ATPase assays with consistent substrate panels and consider the genomic context when interpreting functional differences.
B. xenovorans LB400 contains an exceptionally high number of aromatic degradation pathways (eleven "central aromatic" and twenty "peripheral aromatic" pathways), making it one of the most metabolically versatile bacteria for degrading aromatic compounds, including polychlorinated biphenyls (PCBs) .
The MsbA protein may contribute to this capability through:
Membrane Lipid Homeostasis:
MsbA maintains outer membrane integrity during exposure to toxic aromatic compounds
Facilitates adaptation to hydrophobic substrates by modulating membrane fluidity
Potential Export Functions:
May participate in efflux of aromatic degradation intermediates
Could contribute to cellular detoxification mechanisms when processing aromatic compounds
Integration with Metabolic Networks:
Potentially coordinates with the extensive network of transporters (over 23 aromatic acid transporters) identified in B. xenovorans
May function in conjunction with the many major facilitator superfamily transporters present in the organism
Experimental approaches to verify these roles could include:
Knockout studies examining aromatic compound tolerance
Membrane composition analysis under various growth conditions
Metabolomic profiling comparing wild-type and MsbA-modified strains during aromatic compound metabolism
Multiple complementary approaches can be employed to comprehensively evaluate the functional activity of recombinant B. xenovorans MsbA:
ATP Hydrolysis Assays:
Colorimetric phosphate release assays (malachite green method)
Coupled enzyme assays (pyruvate kinase/lactate dehydrogenase system)
Radioactive [γ-32P]ATP hydrolysis measurements
Lipid A Transport Assays:
Reconstitution in proteoliposomes with fluorescently labeled Lipid A analogs
Inside-out membrane vesicle transport studies
FRET-based assays for monitoring substrate translocation
Structural Dynamics Assessment:
Limited proteolysis to identify conformational changes upon nucleotide binding
Intrinsic tryptophan fluorescence spectroscopy
Circular dichroism (CD) spectroscopy for secondary structure analysis
| Step | Parameter | Condition |
|---|---|---|
| 1. Reaction Buffer | Composition | 50 mM Tris-HCl (pH 7.5), 150 mM NaCl, 5 mM MgCl₂, 10% glycerol, 0.05% DDM |
| 2. Protein Concentration | Range | 0.1-1.0 μg/reaction |
| 3. ATP Concentration | Range | 0-5 mM (for Km determination) |
| 4. Incubation | Time/Temperature | 30 minutes at 37°C |
| 5. Detection | Method | Malachite green phosphate detection (A620) |
| 6. Data Analysis | Parameters | Vmax, Km, and catalytic efficiency (kcat/Km) |
Differentiating the roles of B. xenovorans MsbA from potential functional paralogs requires a multi-faceted approach:
Computational Analysis:
Phylogenetic tree construction to identify true paralogs
Protein domain architecture comparison
Structural modeling to predict functional differences
Promoter analysis to identify differential regulation patterns
Experimental Approaches:
Genetic Manipulation:
Individual and combinatorial gene knockout/knockdown studies
Complementation assays with paralogous genes
Promoter-reporter fusion constructs to monitor expression patterns
Biochemical Characterization:
Side-by-side substrate specificity profiles
Inhibitor sensitivity comparisons
Lipid environment requirements
Protein-Protein Interaction Studies:
Co-immunoprecipitation to identify differential binding partners
Bacterial two-hybrid screens
Cross-linking mass spectrometry
The high rate of gene duplication and divergence in B. xenovorans (17.6% of proteins having better paralogs within the same genome) makes this differentiation particularly important . Researchers should leverage the genomic context information to predict functional differences that can then be experimentally verified.
Solution: Systematically screen detergents (DDM, LDAO, LMNG) at various concentrations to identify optimal solubilization conditions. Add cholesteryl hemisuccinate (CHS) at 0.01-0.05% to stabilize the protein. Consider nanodiscs or styrene-maleic acid lipid particles (SMALPs) for detergent-free extraction.
Solution: Optimize codon usage for expression host, use specialized strains (C41/C43), lower induction temperature (16-20°C), and extend expression time (24-48 hours). Consider fusion partners (MBP, SUMO) to enhance solubility and expression.
Solution: Implement thermal shift assays to assess protein stability. Compare ATPase activity with well-characterized MsbA homologs. Use limited proteolysis to verify native conformation.
Solution: Select lipid compositions that mimic B. xenovorans membrane environment. Test different protein:lipid ratios (1:50 to 1:500) and reconstitution methods (detergent removal by dialysis, Bio-Beads, or cyclodextrin).
| Problem | Possible Cause | Solution |
|---|---|---|
| Low ATPase activity | Detergent inhibition | Change detergent type or reduce concentration |
| Improper folding | Optimize purification conditions, avoid aggregation | |
| Lipid environment | Add specific lipids (E. coli polar extract) to assay | |
| Aggregation during purification | Concentration too high | Maintain below 5 mg/mL during concentration steps |
| Buffer incompatibility | Add glycerol (10%) and ensure adequate detergent | |
| Temperature effects | Perform all steps at 4°C | |
| Poor stability | Oxidation | Add reducing agent (1-5 mM DTT or TCEP) |
| Protease contamination | Include protease inhibitors throughout purification | |
| Detergent loss | Maintain detergent above CMC in all buffers |
Determine basal ATPase activity parameters (Km, Vmax)
Assess nucleotide binding affinities using fluorescence spectroscopy
Characterize pH and temperature optima relevant to B. xenovorans physiology
Include well-characterized MsbA proteins from model organisms (E. coli, Salmonella)
Generate catalytically inactive mutants (Walker A lysine substitution)
Prepare control proteoliposomes without protein
Correlate ATP hydrolysis with substrate transport
Use fluorescence-based real-time assays for transport kinetics
Combine biochemical data with in vivo phenotypic analysis
Test function under conditions mimicking B. xenovorans natural environment:
Temperature ranges (10-30°C)
pH variations (5.5-8.0)
Presence of aromatic compounds metabolized by B. xenovorans
Generate targeted mutations based on sequence alignment with characterized homologs
Focus on residues in the predicted substrate-binding pocket
Examine conserved motifs specific to Burkholderia species
Internal Validity Considerations:
The experimental design must demonstrate convincingly that changes in transport activity are a function of the specific intervention and not the result of uncontrolled factors . This requires:
Appropriate controls for each experiment
Replication to confirm reproducibility
Systematic variation of single parameters
Statistical analysis to determine significance
B. xenovorans LB400 is recognized for its exceptional ability to degrade polychlorinated biphenyls (PCBs) and other environmental pollutants . Future research into its MsbA protein could provide critical insights into bacterial adaptation mechanisms through several avenues:
Membrane Remodeling Mechanisms:
Investigate how MsbA activity changes during exposure to aromatic pollutants
Determine if MsbA facilitates membrane composition alterations that enhance pollutant tolerance
Explore potential correlations between MsbA expression/activity and the activation of aromatic degradation pathways
Comparative Genomics Applications:
Compare MsbA structure and function across Burkholderia strains with varying pollutant degradation capabilities
Identify evolutionary adaptations in MsbA that correlate with expanded metabolic capacity
Analyze whether lateral gene transfer events affecting MsbA contribute to enhanced environmental adaptation
Biotechnological Implications:
Assess whether MsbA modification could enhance bioremediation capabilities
Determine if MsbA engineering could improve whole-cell biocatalysts for environmental applications
Explore MsbA as a potential target for enhancing bacterial survival in contaminated environments
Despite current knowledge, several critical aspects of B. xenovorans MsbA function remain unexplored:
Regulatory Network Integration:
How is MsbA expression regulated in response to environmental stressors?
Does MsbA activity coordinate with the extensive aromatic degradation pathways?
Is there cross-talk between MsbA and the transcriptional regulators like RcoM(Bx)-1 ?
Substrate Specificity:
Beyond Lipid A, what other substrates might B. xenovorans MsbA transport?
Does substrate specificity differ from MsbA proteins in pathogenic Burkholderia species?
Could MsbA participate in export of secondary metabolites or signaling molecules?
Ecological Context:
How does MsbA function contribute to B. xenovorans' survival in its soil and rhizosphere niche?
Is MsbA activity involved in plant-microbe interactions?
Does MsbA play a role in biofilm formation in environmental contexts?
Structural Adaptations:
What structural features distinguish B. xenovorans MsbA from homologs in other species?
How do these structural differences relate to B. xenovorans' environmental adaptability?
Could unique structural elements be exploited for selective inhibition or enhancement?
Addressing these questions will require integrative approaches combining structural biology, molecular genetics, biochemistry, and ecological studies to fully elucidate the multifaceted roles of this important membrane transporter.